: 22429670  [PubMed - indexed for MEDLINE]653. Artif Organs. 2012 Jul;36(7):639-42. doi: 10.1111/j.1525-1594.2011.01428.x. Epub 2012 Mar 16.6 months of "temporary" support by Levitronix left ventricular assist device.Barbone A(1), Malvindi PG, Sorabella RA, Cortis G, Tosi PF, Basciu A, Ferrara P, Raffa G, Citterio E, Settepani F, Ornaghi D, Tarelli G, Vitali E.Author information: (1)UO di Cardiochirurgia, Istituto Clinico Humanitas IRCCS, Rozzano, Milan,Italy. alessandro.barbone@humanitas.itAn otherwise healthy 47-year-old man presented to the emergency department incardiogenic shock after suffering a massive myocardial infarction due to leftmain occlusion. He was initially supported by extracorporeal membrane oxygenationand subsequently was converted to paracorporeal support with a Levitronix leftventricular assist device. He experienced multiple postoperative complicationsincluding renal failure, respiratory failure, retroperitoneal hematoma requiring suspension of anticoagulation, and fungal bloodstream infection precludingtransition to an implantable device. He was reconditioned and successfullyunderwent orthotopic heart transplant 183 days after presentation. A discussionof the relevant issues is included.© 2012, Copyright the Authors. Artificial Organs © 2012, International Center forArtificial Organs and Transplantation and Wiley Periodicals, Inc.